FEATURED ARTICLES

• 5 Best Practices For Getting Started With ePRO

  Unlock the potential of electronic Patient Reported Outcomes (ePRO) in your clinical research by implementing these essential best practices for success.

• Understanding Phase 4 Trials: A Critical Component Of Post-Marketing Insight

  Uncover how Phase 4 trials play an essential role in gathering additional real-world data on the treatment’s performance over a longer period of time and in more diverse patient populations.

• Fulfilling MDR Requirements For A Groundbreaking Microsurgery Robot

  Uncover how Castor accelerated MMI's mission to advance robotic technology and expand the boundaries of open surgery, creating new opportunities for surgeons to restore the quality of life for patients with complex conditions.

• An Expert's View On Choosing And Developing An eCOA Strategy

  Dive into the insights from our recent LinkedIn Live discussion where Derk Arts, CEO of Castor, and Joe Dustin, VP at Biofourmis explored how a standardized approach to eCOA could transform clinical trials and streamline data collection.

• Do We Still Need Patients In Tomorrow's Trials?

  Delve into how advanced technologies reshape drug development and patient care, and the crucial balance needed between innovation and ethical responsibility to achieve better trial outcomes.

• DTx Company Leverages Real-World Evidence Platform In Registry Study

  Discover how Castor’s eClinical system enabled a groundbreaking study in behavioral disorder treatment to collect Real-World Evidence (RWE) to support product research and claims.

• Navigating The Evolving Regulatory And Data Landscape

  Explore how real-world evidence is reshaping clinical research and learn why precision and innovation are key to staying ahead in this evolving landscape.

• 5 Key Takeaways From The FDA's Real-World Evidence Guidance

  With our advanced technology and expertise, sponsors can confidently conduct RWE studies that are efficient and aligned with the FDA’s data-driven vision for healthcare.

• How Optina Diagnostics Used EDC In Earlier Disease Detection

  Understand how Optina Diagnostics streamlined operations and achieved significant milestones by leveraging Castor's tools in its effort to revolutionize the diagnostic process for Alzheimer’s.

• Measuring The True Patient Experience

  Utilizing the insights covered in this article can inform the design and implementation of cancer trials, ultimately contributing to improved patient care and treatment outcomes.

• ISR Report Sheds Light On eCOA/ePRO Market Dynamics

  This comprehensive overview highlights the critical role these platforms play in modern clinical research, emphasizing their impact on data integrity and trial efficiency.

• Evaluating 'Bother' As A Component Of Patient-Reported Outcomes

  Learn how incorporating "bother" as a patient-reported outcome metric aligns research with real-world experiences and drug development with patient needs.

• eConsent Readiness In 24 Countries

  Discover how regulatory bodies worldwide, including the U.S. Food and Drug Administration and the European Medicines Agency, are now championing the shift towards eConsent adoption.

• The Place Of PROs In The Future Of Healthcare

  Discover how integrating Patient-Reported Outcomes can drive alignment with Value-Based Care (VBC) principles, enhancing product marketability and adoption while promoting patient health and quality of life.

• Accelerating AI Innovation In Pharma: Collaboration Vs. Competition

  Here we delve into the debate, informed by insights from panel discussions at SCOPE 2024 on generative AI in clinical research, focusing on technology and data challenges.

• What FDA, EMA Discussion Papers Reveal About AI In Clinical Research

  Learn how having a comprehensive understanding of regulatory perspectives on AI ethics will prove invaluable for researchers evaluating the integration of AI technology into their trials.

• 10 FAQs On eConsent

  Closely examine the challenges of adoption, integration, and compliance measures involving eConsent and gain valuable insights for those contemplating their incorporation in clinical trials.

• Preparing For Post-Market Clinical Follow-Up Under EU MDR

  Gain a better understanding of the primary challenges faced by the life sciences industry's commercial model in response to the updated EU MDR guidelines.

• Impact Of Direct Data Capture On Clinical Trial Timelines

  Explore a broader strategy for shortening clinical trial timelines that encompasses various elements, ranging from enhancing interoperability to implementing AI-driven technologies.

• Essity Uses eConsent To Optimize Enrollment

  See how a global hygiene and health company was able to deploy virtual methods through a strategic partnership to recruit and retain participants, streamline consent, and analyze patient data.